{"doi":"10.1093/jnci/djae336","title":"Acceptability of an organ inventory for cancer screening across gender identity and intersex status","abstract":"OBJECTIVES: To evaluate the acceptability and performance of an organ inventory as an alternative to asking about gender and/or sex assigned at birth in cancer screening. METHODS: We fielded an online, self-administered survey to a convenience sample of English- or Spanish-speaking transgender and gender-diverse (TGD), intersex, and cisgender people (≥15 years) in the United States. The survey contained an organ inventory developed with community input and questions regarding acceptability. The primary outcome was organ inventory acceptability by the 4-item Acceptability of Intervention Measure (AIM). Additional outcomes included inter-method screening agreement between the organ inventory, gender, and sex assigned at birth. RESULTS: In 2022, 333 eligible individuals completed the survey: 44.4% cisgender, 34.2% TGD, and 14.1% intersex. Overall, participants rated the organ inventory as acceptable (median AIM score = 18/20, IQR: 16-20). Most of them found it easy to understand (73%) and comfortable to complete (65%). Cancer screening eligibility varied based on the method used; relying solely on gender or sex data would have missed some eligible participants that the organ inventory identified. CONCLUSIONS: Using an organ inventory as an alternative to gender- or sex-based screening questions was acceptable and has implications for addressing cancer screening disparities.","journal":"JNCI Journal of the National Cancer Institute","year":2024,"id":451153,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":4,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9528,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1059271,"name":"Sachiko Ragosta","orcid":"0000-0002-2776-0638","position":1,"is_corresponding":false},{"id":412011,"name":"Anu Manchikanti Gómez","orcid":"0000-0002-9461-4411","position":2,"is_corresponding":false},{"id":706234,"name":"Janelle Downing","orcid":"0000-0002-2382-5537","position":3,"is_corresponding":false},{"id":461177,"name":"Jay W Zussman","orcid":"0000-0003-4727-0289","position":4,"is_corresponding":false},{"id":1272605,"name":"Bori Lesser-Lee","orcid":null,"position":5,"is_corresponding":false},{"id":1272606,"name":"S Reese","orcid":null,"position":6,"is_corresponding":false},{"id":1272607,"name":"India Rose Carter-Bolick","orcid":null,"position":7,"is_corresponding":false},{"id":259491,"name":"Juno Obedin‐Maliver","orcid":"0000-0002-0945-2842","position":8,"is_corresponding":false},{"id":757509,"name":"Heidi Moseson","orcid":"0000-0002-2488-2429","position":0,"is_corresponding":true}],"reference_count":22,"raw_metadata":null,"created_at":"2026-07-19T02:02:41.417944Z","pmid":"39672797","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}